Mario Alfredo Eisenberger
Professor of Oncology
Oncology - Prostate Cancer and GU
Johns Hopkins University
United States of America
Biography
Dr. Mario A. Eisenberger is a medical oncologist at Sibley Memorial Hospital, as well as a professor of urology and oncology at the Johns Hopkins University School of Medicine. He is board certified in internal medicine and medical oncology. He practices out of Sibley Memorial Hospital in Washington, D.C., Johns Hopkins Sidney Kimmel Comprehensive Cancer Center in Baltimore, Md. and Johns Hopkins Medicine - Green Spring Station in Lutherville, Md. Dr. Eisenberger has an expertise in cancers of the bladder, kidney, prostate and testicles. Dr. Eisenberger earned his medical degree from Federal University of Rio de Janeiro. He completed a residency in internal medicine at Michael Reese Hospital and Medical Center, followed by a hematology fellowship. Dr. Eisenberger also completed a fellowship in medical oncology at Jackson Memorial Hospital. He was previously a senior investigator for the Cancer Therapy Evaluation Program of the National Cancer Institute and chief of oncology at the Baltimore Veterans Administration Hospital. Dr. Dunne has also held faculty appointments at the University of Miami and the University of Maryland. Dr. Eisenberger has been repeatedly named one of America’s Top Doctors and one of America’s Top Doctors for Cancer by Castle Connolly. He is a member of the American Association of Cancer Research, the National Prostate Cancer Education Council and the International Task Force of the American Society of Clinical Oncology. Dr. Eisenberger has contributed to numerous clinical trials, publications and presentations. He has presented on the systemic treatment of prostate cancer for the President’s Cancer Panel and was a participant in the World Health Organization international panel to update directives and standardize methodology of clinical trials in advanced prostate cancer. Dr. Eisenberger has also won the Clinical Investigator Award by the Prostate Cancer Foundation.
Research Interest
Urological oncology; Testicular cancer; Prostate cancer; Medical oncology; Kidney cancer; General internal medicine; Bladder cancer
Publications
-
Pond GR, Sonpavde G, de Wit R, Eisenberger MA, Tannock IF, Armstrong AJ. ‘The prognostic importance of metastatic site in men with metastatic castration-resistant prostate cancer." Eur Urol. 2014 Jan;65(1):3-6.
-
Paller CJ, Antonarakis ES, Eisenberger MA, Carducci MA. "Management of patients with biochemical recurrence after local therapy for prostate cancer." Hematol Oncol Clin North Am. 2013 Dec;27(6):1205-19.
-
Peer A, Gottfried M, Sinibaldi V, Carducci MA, Eisenberger MA, Sella A, Leibowitz-Amit R, Berger R, Keizman D. "Comparison of abiraterone acetate versus ketoconazole in patients with metastatic castration resistant prostate cancer refractory to docetaxel." Prostate. 2013 Dec 11.
